Corey Miller

Corey Miller is an immunologist and T cell biologist known for his expertise in thymus function, T cell development, and T cell-mediated immunity with a focus on stromal-immune crosstalk. He is recognized in the academic community for his work on understanding how the thymus contributes to a diverse and functional peripheral T cell compartment. As the CEO of Tendel Therapies, Corey is dedicated to advancing a new generation of memory-promoting vaccine adjuvants for infectious diseases and cancer.

Corey's educational background includes a Doctor of Medicine (M.D.) from the University of California, San Francisco, a Doctor of Philosophy (Ph.D.) specializing in HIV Immunology & Stromal-Immune Crosstalk from the University of California, San Francisco, a Bachelor of Science (B.S.) in Biochemistry from the University of Michigan, and a Visiting Scholar program in Biochemistry from the University of Oxford.

Throughout his career, Corey Miller has been associated with various organizations. He has served as an Assistant Professor at the University of California, San Francisco, as the CEO of Tendel Therapies, as a Postdoctoral Scholar at the Anderson Lab at UCSF, and has experience as a Harvest Assistant Winemaker at Favia Erickson Winegrowers. He also completed the Medical Scientist Training Program (MD/PhD) at UCSF.